Neuropeptides in atopic dermatitis.
Giannetti
A
A
Department of Dermatology University of Modena, Italy.
D001249:Asthma / Q000503:physiopathology; D016535:Bronchial Hyperreactivity / Q000503:physiopathology; D003876:Dermatitis, Atopic / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007271:Injections, Intradermal; D015603:Keratinocytes / Q000378:metabolism; D009130:Muscle, Smooth / Q000378:metabolism; D015213:Neuroimmunomodulation; D009479:Neuropeptides / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology*; D011537:Pruritus / Q000139:chemically induced / Q000503:physiopathology; D018013:Receptors, Neuropeptide / Q000502:physiology; D012130:Respiratory Hypersensitivity / Q000503:physiopathology; D012137:Respiratory System / Q000378:metabolism*; D012867:Skin / Q000378:metabolism*
D009479:Neuropeptides; D018013:Receptors, Neuropeptide